Dallas, TX -- (SBWIRE) -- 06/10/2015 -- The medical membranes market is projected to register approximately $7.2 billion by 2020, with the high market share held by Asia-Pacific and North America together due to high prevalence of diabetes and end-stage renal disease (ESRD) and increase in the pharmaceutical, healthcare, biotechnology, and life science industry in the medical membranes market. The global medical membrane market by value is projected to grow at a CAGR of around 9.7% from 2015 to 2020. The high growth is forecasted to be in the Asia-Pacific countries due rising inclination of people to spend, rising prevalence of diabetes and increasing healthcare market. Browse 63 market data tables & 48 figures spread through 166 pages and in-depth TOC on " Global Medical Membranes Market " at http://www.rnrmarketresearch.com/medical-membranes-market-by-chemistry-ptfe-pvdf-pe-modified-acrylics-and-others-by-technology-ultrafiltration-microfiltration-reverse-osmosis-dialysis-gas-separation-others-by-applicatio-market-report.html

The medical membranes market is flourishing across the developed as well as developing regions as the medical device manufacturers and other medical professionals are willing to explore new advanced products and the manufacturers are focusing on R&D to launch new products. The continuous rise in medical market, increasing use of single-use disposable products, and rise in demand for high purity products due to tightening regulations are driving the demand for medical membranes market across the world. Hemodialysis, IV infusion filters & sterile filtration, and drug delivery are the significant applications. Hemodialysis and drug delivery products are also projected to witness significant growth by 2020.

Microfiltration, ultrafiltration, reverse osmosis, dialysis, and gas separation are the major technologies used by medial membranes. Microfiltration, reverse osmosis, and ultrafiltration are the major technologies.

The medical membranes market is anticipated to show a high growth rate in the coming years. The market is driven by rising incident rates of diseases like diabetes, innovations in medical membranes, and rising healthcare and pharmaceutical market which is expected to provide new opportunities for medical membranes market. Problems of membrane fouling, high capital and operation cost, and limitations of membrane materials are the factors that are inhibiting the growth of the market. There are large numbers of various sized players in the market.

Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=391554

Currently, the medical membranes market is mainly concentrated in the North American, European and Asia-Pacific region while Middle East & African and Latin American region, are expected to show high growth rate in future years. The expanding healthcare market along with developing economy is the factors because of which the medical membranes market is projected to grow at a significant rate in next five years in these regions.

Dow Chemicals (the U.S.), GE Healthcare (the U.S.), Merck Millipore (the U.S.), Polypore International Inc. (the U.S.), Sartorius (Germany), and Pall Corporation (the U.S.) are the important players in the medical membranes market. These companies showed the highest strategy adoptions amongst other players in medical membranes market from 2011 to 2015. From 2011 to 2015, partnership, agreement, & collaboration and merger & acquisition were observed as the most important growth strategy adopted by the major medical membranes manufacturers, accounting for a majority of market share of the total strategies adopted by the players. The players also significantly focused on R&D and new product launch. Priced at $4650 for a single user PDF, a discount on "Medical Membranes Market by Chemistry (PTFE, PVDF, PE, Modified Acrylics and Others), by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis, Dialysis, Gas Separation, Others), by Application (Hemodialysis, Drug delivery, IV Infusion Filters & Sterile Filtration, Others), and Geography – Trends & Forecast to 2020" research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=391554

Related Market Reports:

"North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) – Forecasts To 2017" research report is now available with RnRMarketResearch.com. Key players in the drug delivery technologies market are 3M Company (U.S.), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton, Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.) and Valeant Pharmaceuticals (Canada) are discussed in this research available at http://www.rnrmarketresearch.com/north-american-drug-delivery-technologies-market-metered-dose-inhalers-needle-free-injectors-auto-injectors-nasal-sprays-transdermal-patches-nebulizers-infusion-pumps-drug-eluting-stents-sust-market-report.html

Explore more Drug Delivery Market Research Reports at
http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/drug-delivery

About RnRMarketResearch.com
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.